These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 6517649

  • 21. Cardiac versus coronary vasodilator actions of isobutylmethylxanthine in dogs: comparison with theophylline.
    Takahashi K, Wada Y, Taira N.
    Jpn J Pharmacol; 1986 May; 41(1):23-32. PubMed ID: 2426501
    [Abstract] [Full Text] [Related]

  • 22. Inotropic versus chronotropic, dromotropic, and coronary vasodilator actions of DPI 201-106, a novel positive inotropic agent, in the dog heart.
    Takahashi K, Endoh M, Taira N.
    J Cardiovasc Pharmacol; 1987 Apr; 9(4):451-60. PubMed ID: 2438508
    [Abstract] [Full Text] [Related]

  • 23. Coronary vasodilator compared to cardiac effects of PY 108-068, a new dihydropyridine vasodilator, on isolated, blood-perfused dog-heart preparations.
    Wada Y, Satoh K, Taira N.
    J Cardiovasc Pharmacol; 1984 Apr; 6(5):881-7. PubMed ID: 6209495
    [Abstract] [Full Text] [Related]

  • 24. Comparative study of MDL 17043 and MDL 19205, new positive inotropic agents, by use of isolated, blood-perfused dog-heart preparations.
    Wada Y, Taira N.
    Heart Vessels; 1986 Apr; 2(1):29-35. PubMed ID: 2941407
    [Abstract] [Full Text] [Related]

  • 25. Profile of cardiac and coronary vasodilator effects of MS-857, a novel cardiotonic agent, assessed in isolated, blood-perfused heart preparations of the dog.
    Maruyama M, Kamiya J, Kobari T.
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):777-82. PubMed ID: 2481193
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Is the cardiovascular profile of BRL 34915 characteristic of potassium channel activators?
    Gotanda K, Satoh K, Taira N.
    J Cardiovasc Pharmacol; 1988 Aug; 12(2):239-46. PubMed ID: 2459556
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Comparative study of cardiovascular profiles of milrinone and amrinone by use of isolated, blood-perfused dog heart preparations.
    Sato Y, Wada Y, Taira N.
    Heart Vessels; 1986 Aug; 2(4):213-20. PubMed ID: 3571104
    [Abstract] [Full Text] [Related]

  • 30. Cardiac effects of amiloride in the dog.
    Yamashita S, Motomura S, Taira N.
    J Cardiovasc Pharmacol; 1981 Aug; 3(4):704-15. PubMed ID: 6167801
    [Abstract] [Full Text] [Related]

  • 31. Mode and mechanism of action of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, on the dog heart.
    Taira N, Endoh M, Iijima T, Satoh K, Yanagisawa T, Yamashita S, Maruyama M, Kawada M, Morita T, Wada Y.
    Arzneimittelforschung; 1984 Aug; 34(3A):347-55. PubMed ID: 6331465
    [Abstract] [Full Text] [Related]

  • 32. Characterization of cardiovascular actions of CS-611, a new coronary dilator, in the dog.
    Motomura S, Satoh K, Yamashita S, Taira N.
    Arzneimittelforschung; 1981 Aug; 31(8):1238-44. PubMed ID: 7197528
    [Abstract] [Full Text] [Related]

  • 33. Mechanisms underlying the cardiovascular action of a new dihydropyridine vasodilator YC-93.
    Satoh K, Yanagisawa T, Taira N.
    Clin Exp Pharmacol Physiol; 1980 Aug; 7(3):249-62. PubMed ID: 7406961
    [Abstract] [Full Text] [Related]

  • 34. Cardiac electrophysiological effects of falipamil in the conscious dog: comparison with alinidine.
    Boucher M, Chassaing C, Chapuy E.
    Eur J Pharmacol; 1996 Jun 13; 306(1-3):93-8. PubMed ID: 8813620
    [Abstract] [Full Text] [Related]

  • 35. Bradycardic effects of AQ-A 39 (falipamil) in situ and in isolated, blood-perfused dog hearts. Comparison with alinidine and verapamil.
    Ogiwara Y, Furukawa Y, Akahane K, Haniuda M, Chiba S.
    Jpn Heart J; 1988 Nov 13; 29(6):849-61. PubMed ID: 3241338
    [Abstract] [Full Text] [Related]

  • 36. Cardiac electrophysiologic effects of alinidine, a specific bradycardic agent, in the conscious dog: plasma concentration-response relations.
    Boucher M, Chassaing C, Chapuy E.
    J Cardiovasc Pharmacol; 1995 Feb 13; 25(2):229-33. PubMed ID: 7752648
    [Abstract] [Full Text] [Related]

  • 37. Coronary vasodilator versus cardiac effects of MCI-176, a novel quinazolinone calcium antagonist, in the dog heart.
    Hosono M, Taira N.
    J Cardiovasc Pharmacol; 1987 Jun 13; 9(6):633-40. PubMed ID: 2442528
    [Abstract] [Full Text] [Related]

  • 38. Comparative effects of adenosine triphosphate on automaticity and conduction in human cardiac tissue.
    Sharma AD, Klein GJ.
    Prog Clin Biol Res; 1987 Jun 13; 230():315-28. PubMed ID: 3588604
    [Abstract] [Full Text] [Related]

  • 39. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
    Uchida Y, Kawada M, Sawanobori K, Sonoki H, Inoue K, Mizuno K, Itou T, Tabunoki Y, Tsukamoto M, Ohashi Y, Kyotani Y, Shimizu N, Fujii M, Nakamura M.
    Arzneimittelforschung; 1998 Mar 13; 48(3):219-31. PubMed ID: 9553677
    [Abstract] [Full Text] [Related]

  • 40. Comparative study of cardiovascular effects of clonidine and alinidine in cross-perfused dog atrial preparations.
    Chiba S, Ogiwara Y, Furukawa Y, Akahane K.
    Jpn Heart J; 1989 Nov 13; 30(6):895-902. PubMed ID: 2632839
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.